Bayer and J&J beat FCA lawsuit over antibiotic claims

By Jeannie O’Sullivan (April 1, 2022, 5:15 p.m. EDT) – A federal judge in New Jersey has launched a lawsuit that tam accuses Bayer Corp. and Johnson & Johnson of defrauding federal insurance programs over antibiotic labeling deficiencies, saying the complaints need further clarification to move forward.

In a ruling on Thursday, U.S. District Judge Esther Salas agreed with the drug companies’ argument that Charles L. Bennett’s complaint, which was directed at the defendants’ failure to disclose potential side effects of Cipro and Levaquin, did not plead the element of falsity. of the Misrepresentation Act.

“First, the Amended Complaint does not distinguish between Bayer and J&J – two separate entities…

Stay one step ahead

In the legal profession, information is the key to success. You need to know what’s going on with customers, competitors, practice areas and industries. Law360 provides the intelligence you need to stay an expert and beat the competition.

  • Access to case data in articles (numbers, filings, courts, nature of lawsuits, etc.)
  • Access to attached documents such as briefs, motions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and more!



About Author

Comments are closed.